Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-02-18

FDA Approved: EPIDUO — Supplemental Application (Galderma Laboratories, L.P.)

View source ↗

Summary

The FDA approved a supplemental application for Epiduo (adapalene and benzoyl peroxide) from Galderma Laboratories, L.P. This action updates the product labelin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPIDUO (adapalene and benzoyl peroxide)

Snippet

SUPPL AP for EPIDUO (ADAPALENE AND BENZOYL PEROXIDE)